Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2020 2
2021 1
2022 3
2023 4
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Vivarelli M, Barratt J, Beck LH Jr, Fakhouri F, Gale DP, Goicoechea de Jorge E, Mosca M, Noris M, Pickering MC, Susztak K, Thurman JM, Cheung M, King JM, Jadoul M, Winkelmayer WC, Smith RJH; for Conference Participants. Vivarelli M, et al. Kidney Int. 2024 Sep;106(3):369-391. doi: 10.1016/j.kint.2024.05.015. Epub 2024 Jun 4. Kidney Int. 2024. PMID: 38844295 Free article.
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial.
Barratt J, Liew A, Yeo SC, Fernström A, Barbour SJ, Sperati CJ, Villanueva R, Wu MJ, Wang D, Borodovsky A, Badri P, Yureneva E, Bhan I, Cattran D; Cemdisiran Phase 2 Study Investigators and Collaborators. Barratt J, et al. Clin J Am Soc Nephrol. 2024 Apr 1;19(4):452-462. doi: 10.2215/CJN.0000000000000384. Epub 2024 Jan 15. Clin J Am Soc Nephrol. 2024. PMID: 38214599 Free article. Clinical Trial.
Focal Segmental Glomerulosclerosis: Assessing the Risk of Relapse.
Troyanov S, Jauhal A, Reich HN, Hladunewich MA, Cattran DC; Toronto Glomerulonephritis Registry Group. Troyanov S, et al. Among authors: jauhal a. Kidney Int Rep. 2023 Sep 9;8(11):2403-2415. doi: 10.1016/j.ekir.2023.08.035. eCollection 2023 Nov. Kidney Int Rep. 2023. PMID: 38025232 Free PMC article.
Focused Jurisdictional Scan of Glomerulonephritis Medication Access in Canada: A Program Report.
Naipaul R, Marques C, Ng J, Barbour S, Lo C, Hildebrand AM, Siu V, Prasad B, Laurin LP, Wazny LD, Armstrong S, Tran J, Sheffield M, Jauhal A, Hladunewich MA. Naipaul R, et al. Among authors: jauhal a. Can J Kidney Health Dis. 2023 Aug 12;10:20543581231190227. doi: 10.1177/20543581231190227. eCollection 2023. Can J Kidney Health Dis. 2023. PMID: 37581108 Free PMC article.
Synthetic ACTH for Treatment of Glomerular Diseases: A Case Series.
Jauhal A, Prasad B, Rousseau-Gagnon M, Ouellet G, A Hladunewich M. Jauhal A, et al. Can J Kidney Health Dis. 2022 Jan 5;9:20543581211066979. doi: 10.1177/20543581211066979. eCollection 2022. Can J Kidney Health Dis. 2022. PMID: 35024153 Free PMC article.
16 results